a

Pa Okutobala 12, 2024, JYMed's Liraglutide API idalandira satifiketi Yotsimikizika Yolembedwa (WC), zomwe zikuwonetsa gawo lofunikira pakutumiza bwino kwa API kumsika wa EU.

1 (2)

TheWC (Chitsimikizo Cholembedwa)ndichinthu chofunikira potumiza ma API kuchokera kumayiko omwe si a EU kupita kumsika wa EU. Choperekedwa ndi olamulira a dziko lotumiza kunja, satifiketi iyi imawonetsetsa kuti API yotumizidwa kunja ikutsatiraKuchita Zabwino Zopanga (GMP)miyezo yokhazikitsidwa ndi EU. Zimagwira ntchito yofunika kwambiri pakuwonetsetsa kuti ma API ali abwino komanso otetezeka ndipo ndizofunikira kwa mayiko omwe si a EU omwe akufuna mwayi wopeza msika wamankhwala wa EU.

1 (3)
1 (4)

Kulandila satifiketi ya WC ya Liraglutide API sikungowonetsa kuzindikirika kwamtundu ndi chitetezo cha zinthu za JYMed komanso kumathandizira kuti kampaniyo ikhale ndi luso lokulitsa kupezeka kwake pamsika wa EU API. Kupindula kumeneku kumalimbitsa udindo wa JYMed pamakampani opanga mankhwala padziko lonse lapansi, kupereka mwayi waukulu wachitukuko ndikuwonjezera mbiri yake padziko lonse lapansi.

Za JYMed

1 (5)

Shenzhen JYMed Technology Co., Ltd. (yomwe tsopano imatchedwa JYMed) idakhazikitsidwa mu 2009, ikuchita kafukufuku, chitukuko, kupanga, ndi malonda a peptides ndi zinthu zokhudzana ndi peptide. Ndi malo amodzi ofufuzira komanso maziko atatu opangira, JYMed ndi amodzi mwa omwe amapanga ma API a peptide opangidwa ndi mankhwala ku China. Gulu lalikulu la R&D la kampaniyo limadzitamandira kwazaka zopitilira 20 pantchito ya peptide ndipo ladutsa bwino pakuwunika kwa FDA kawiri. Dongosolo lambiri komanso logwira mtima la ma peptide la JYMed limapatsa makasitomala ntchito zambiri, kuphatikiza kupanga ndi kupanga ma peptides achire, ma peptides anyama, antimicrobial peptides, ndi cosmetic peptides, komanso kulembetsa ndi kuthandizira pakuwongolera.

Zochita Zazikulu Zamalonda

1.Kulembetsa kwapakhomo komanso kumayiko ena kwa ma peptide API

2.Veterinary and cosmetic peptides

3.Custom peptides ndi CRO, CMO, OEM misonkhano

4.PDC mankhwala (peptide-radionuclide, peptide-yaing'ono molekyulu, peptide-mapuloteni, peptide-RNA)

Kuphatikiza pa Tirzepatide, JYMed yatumiza zolemba zolembetsa ndi FDA ndi CDE pazinthu zina zingapo za API, kuphatikiza mankhwala odziwika bwino a GLP-1RA monga Semaglutide ndi Liraglutide. Makasitomala amtsogolo omwe akugwiritsa ntchito zinthu za JYMed azitha kulozera mwachindunji nambala yolembetsa ya CDE kapena nambala ya fayilo ya DMF potumiza mafomu olembetsa ku FDA kapena CDE. Izi zidzachepetsa kwambiri nthawi yofunikira pokonzekera zikalata zofunsira, komanso nthawi yowunikira komanso mtengo wowunikiranso zinthu.

1 (6)

Lumikizanani nafe

f
1 (7)

Malingaliro a kampani Shenzhen JYMed Technology Co., Ltd.

Address: 8th & 9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Foni: +86 755-26612112
Webusaiti:http://www.jymedtech.com/


Nthawi yotumiza: Oct-17-2024
ndi